Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell LPA Group (LPA) by Steve Moore in ShareProphets
- Sell Chill Brands Group (CHLL) by Tom Winnifrith in ShareProphets
- Hold Pebble Beach Systems Group (PEB) by Hot Stock Rockets in ShareProphets
- Avoid Stelrad Group (SRAD) by Steve Moore in ShareProphets
- Avoid Transense Technologies (TRT) by Steve Moore in ShareProphets
- Buy BAE Systems (BA.) by Simon Watkins in The Motley Fool
- Buy Man Group (EMG) by UBS
- Hold Synthomer (SYNT) by Deutsche Bank
- Sell Lloyds Banking Group (LLOY) by Shore Capital
- Outperform 3i Infrastructure (3IN) by RBC Capital
- Buy Polar Capital Holdings (POLR) by Deutsche Bank
- Hold Jupiter Fund Management (JUP) by Deutsche Bank
- Sell Liontrust Asset Management (LIO) by Deutsche Bank
- Buy Anglo American (AAL) by Citi
- Outperform Phoenix Group Holdings (PHNX) by RBC Capital
- Sector Perform M&G (MNG) by RBC Capital
- Underperform Legal & General Group (LGEN) by RBC Capital
- Outperform Aviva (AV.) by RBC Capital
- Underweight WPP (WPP) by Barclays
- Overweight South32 Limited (DI) (S32) by Barclays
Poolbeg Pharma (POLB) Share Price
Health Care Sector
NOTE: This is based on 2 open tips for Poolbeg Pharma (POLB)
| Latest Bid : 4.20p | Latest Ask : 4.60p |
| High Today : 4.60p | Low Today : 4.20p |
| This Years High : 5.15p | This Years Low : 2.40p |
| Volume : 712,131 | MKT Cap : £22M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Poolbeg Pharma (POLB) Overview
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the "one-stop shop" for Big Pharma seeking mid-stage products to license or acquire.Poolbeg Pharma (POLB) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Watch | Edward Sheldon | Premium Only | 2024-05-15 09:45:00 15/05/2024 | – |
| Buy | Joanne Hart | Premium Only | 2021-08-22 14:55:00 22/08/2021 | 39.01% |
Poolbeg Pharma (POLB) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 4.20p | Latest Ask : 4.60p |
| High Today : 4.60p | Low Today : 4.20p |
| This Years High : 5.15p | This Years Low : 2.40p |
| Volume : 712,131 | MKT Cap : £22M |
Poolbeg Pharma Overview
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the "one-stop shop" for Big Pharma seeking mid-stage products to license or acquire.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Poolbeg Pharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Watch | Edward Sheldon | Premium Only | 2024-05-15 09:45:00 15/05/2024 | – |
| Buy | Joanne Hart | Premium Only | 2021-08-22 14:55:00 22/08/2021 | 39.01% |